Benefit of CFAE Ablation (BOCA)
A Study to Investigate the Benefit Of Complex Fractionated Atrial Electrogram (CFAE) Ablation in Addition to Circumferential Pulmonary Vein and Linear Ablations in the Treatment of Persistent Atrial Fibrillation. (BOCA)
Sponsor: Oxford University Hospitals NHS Trust
This NA trial investigates Persistent Atrial Fibrillation and is currently completed. Oxford University Hospitals NHS Trust leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Unknown Status → Completed
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Unknown Status NA
First recorded
Mar 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Oxford University Hospitals NHS Trust
- Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .